MARKET

SHLT

SHLT

SHL Telemed
NASDAQ
5.01
+0.36
+7.74%
After Hours: 4.500 -0.51 -10.18% 16:00 05/06 EDT
OPEN
4.770
PREV CLOSE
4.650
HIGH
5.01
LOW
4.770
VOLUME
260
TURNOVER
0
52 WEEK HIGH
12.75
52 WEEK LOW
4.620
MARKET CAP
82.13M
P/E (TTM)
-11.5518
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at SHLT last week (0429-0503)?
Weekly Report · 1d ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Cyclacel Pharmaceuticals (NASDAQ:CYCC) stock moved upwards by 50.0% to $2.04 during Tuesday's pre-market session. GeneDx Hldgs shares rose 43.54% as the company's market cap rose to $411.3 million. Tenet Healthcare (NYSE:THC) stock increased by 9.93% after their Q1 earnings report came out yesterday.
Benzinga · 04/30 12:06
Weekly Report: what happened at SHLT last week (0422-0426)?
Weekly Report · 04/29 10:43
Weekly Report: what happened at SHLT last week (0415-0419)?
Weekly Report · 04/22 10:36
SHL Telemedicine reports FY results
Seeking Alpha · 04/17 09:18
SHL Announces Full-Year 2023 Results - Stable Revenue Growth Alongside Groundbreaking Clinical Milestones
SHL Telemedicine Ltd. Announced its results for the full-year 2023. Total revenues rose to $57.1m. Revenues from the company's operation in Israel increased by 2.3%. In the US, the company launched direct-to-consumer sales of the SmartHeart® ECG platform.
Barchart · 04/17 04:00
Weekly Report: what happened at SHLT last week (0408-0412)?
Weekly Report · 04/15 10:29
Imperial College Study Reveals SHL Telemedicine's SmartHeart® Drastically Cuts Hospital Readmissions By 76% And Lowers Emergency Visits By 41%
Groundbreaking Study reveals a 76% drop in hospital readmissions and a 41% decrease in Emergency Department visits for post-MI heart attack patients at home. The results of the Imperial College London TELE-ACS trial underscore SmartHeart's pivotal role in remote cardiac care.
Benzinga · 04/11 07:30
More
About SHLT
SHL Telemedicine Ltd (SHL) is an Israel-based company engaged in developing and marketing personal telemedicine solutions, with a focus on cardiovascular and related diseases. Personal telemedicine is the transmission of medical data by an individual, from a remote location, to a medical call center through telecommunication networks. SHL’s platform offers solutions to subscribing patients, health insurance companies, hospitals, clinics, physicians and other health care providers. Its solutions for healthcare professionals include: CHF monitoring service that supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease, and Readmission Solutions for reducing heart-related readmissions. Its consumers' solutions include Cardiac Monitoring Service.

Webull offers SHL Telemedicine Ltd stock information, including NASDAQ: SHLT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SHLT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SHLT stock methods without spending real money on the virtual paper trading platform.